• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以治疗为重点的埃博拉试验、支持性护理和丝状病毒护理的未来。

Treatment-focused Ebola trials, supportive care and future of filovirus care.

机构信息

a Division of Infectious Diseases, Department of Medicine , Johns Hopkins University School of Medicine , Baltimore , MD , USA.

b Division of Medicine , United States Army Medical Research Institute of Infectious Diseases , Frederick , MD , USA.

出版信息

Expert Rev Anti Infect Ther. 2018 Jan;16(1):67-76. doi: 10.1080/14787210.2018.1413937. Epub 2017 Dec 20.

DOI:10.1080/14787210.2018.1413937
PMID:29210303
Abstract

During the 2014-2016 Ebolavirus (EBOV) outbreak, several candidate therapeutics were used in EBOV-infected patients in clinical trials and under expanded access for emergency use. This review will focus briefly on medications used during the outbreak. We will discuss current therapeutic candidates and their status and will then turn to a related and essential topic: supportive care and the standard of care for filovirus infected patients. Potential benefits and pitfalls of combination therapies for filoviruses will be discussed. Areas covered: Clinical trials of therapeutics targeting EBOV; clinical usage of therapeutics during recent EBOV outbreak; potential need for combination therapy; role of supportive care in treatment of Ebola virus disease (EVD). Expert commentary: In the absence of another large scale EBOV outbreak, the path to therapeutic product licensure in the United States of America (USA) would need to be via the FDA Animal Rule. However, human data may be needed to supplement animal data. The future of filovirus therapeutics may therefore benefit by establishing the ability to implement clinical trials in an outbreak setting in a timely fashion. Supportive care guidelines for filovirus infection should be defined and established as standard of care for treatment of EVD.

摘要

在 2014-2016 年埃博拉病毒(EBOV)爆发期间,几种候选疗法在临床试验中用于 EBOV 感染患者,并根据扩大的紧急用途获得了许可。这篇综述将简要聚焦于在疫情期间使用的药物。我们将讨论当前的治疗候选药物及其现状,然后转向一个相关且重要的话题:支持性护理以及丝状病毒感染患者的标准护理。我们将讨论联合疗法治疗丝状病毒的潜在益处和陷阱。涵盖的领域:针对 EBOV 的治疗方法的临床试验;最近 EBOV 爆发期间治疗方法的临床应用;对联合疗法的潜在需求;支持性护理在治疗埃博拉病毒病(EVD)中的作用。专家评论:在没有另一次大规模 EBOV 爆发的情况下,在美国获得治疗产品许可的途径将需要通过 FDA 动物规则。然而,可能需要补充动物数据的人类数据。因此,丝状病毒疗法的未来可能会通过及时建立在疫情环境中实施临床试验的能力而受益。丝状病毒感染的支持性护理指南应作为 EVD 治疗的标准护理加以确定和制定。

相似文献

1
Treatment-focused Ebola trials, supportive care and future of filovirus care.以治疗为重点的埃博拉试验、支持性护理和丝状病毒护理的未来。
Expert Rev Anti Infect Ther. 2018 Jan;16(1):67-76. doi: 10.1080/14787210.2018.1413937. Epub 2017 Dec 20.
2
Antiviral therapeutics for the treatment of Ebola virus infection.用于治疗埃博拉病毒感染的抗病毒疗法。
Curr Opin Pharmacol. 2016 Oct;30:138-143. doi: 10.1016/j.coph.2016.08.016.
3
Treatment of ebola virus disease.埃博拉病毒病的治疗
Pharmacotherapy. 2015 Jan;35(1):43-53. doi: 10.1002/phar.1545.
4
Progression of Ebola Therapeutics During the 2014-2015 Outbreak.2014-2015 年埃博拉疫情期间的治疗方法进展。
Trends Mol Med. 2016 Feb;22(2):164-173. doi: 10.1016/j.molmed.2015.12.005. Epub 2016 Jan 13.
5
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.泛埃博拉病毒和泛丝状病毒小鼠单克隆抗体:对埃博拉病毒和苏丹病毒的保护作用
J Virol. 2015 Oct 14;90(1):266-78. doi: 10.1128/JVI.02171-15. Print 2016 Jan 1.
6
Development of experimental and early investigational drugs for the treatment of Ebola virus infections.用于治疗埃博拉病毒感染的实验性和早期研究性药物的研发。
Expert Opin Investig Drugs. 2015;24(8):999-1011. doi: 10.1517/13543784.2015.1052403. Epub 2015 Jun 12.
7
Evaluation of RealStar Reverse Transcription-Polymerase Chain Reaction Kits for Filovirus Detection in the Laboratory and Field.用于实验室和现场丝状病毒检测的RealStar逆转录-聚合酶链反应试剂盒评估
J Infect Dis. 2016 Oct 15;214(suppl 3):S243-S249. doi: 10.1093/infdis/jiw246. Epub 2016 Aug 21.
8
Current status of small molecule drug development for Ebola virus and other filoviruses.埃博拉病毒和其他丝状病毒小分子药物研发的现状。
Curr Opin Virol. 2019 Apr;35:42-56. doi: 10.1016/j.coviro.2019.03.001. Epub 2019 Apr 16.
9
Filoviruses: One of These Things is (not) Like the Other.丝状病毒:其中之一(并不)与其他的相同。
Viruses. 2015 Sep 29;7(10):5172-90. doi: 10.3390/v7102867.
10
Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.靶向丝状病毒糖蛋白内新型保守表位的猕猴单克隆抗体。
J Virol. 2015 Oct 14;90(1):279-91. doi: 10.1128/JVI.02172-15. Print 2016 Jan 1.

引用本文的文献

1
Role of VP30 Phosphorylation in Ebola Virus Nucleocapsid Assembly and Transport.VP30 磷酸化在埃博拉病毒核衣壳组装和运输中的作用。
J Virol. 2022 Sep 14;96(17):e0108322. doi: 10.1128/jvi.01083-22. Epub 2022 Aug 22.
2
Detection and Prevention of Virus Infection.病毒感染的检测与预防。
Adv Exp Med Biol. 2022;1368:21-52. doi: 10.1007/978-981-16-8969-7_2.
3
The Integrity of the YxxL Motif of Ebola Virus VP24 Is Important for the Transport of Nucleocapsid-Like Structures and for the Regulation of Viral RNA Synthesis.
埃博拉病毒 VP24 的 YxxL 基序的完整性对于核衣壳样结构的运输和病毒 RNA 合成的调节很重要。
J Virol. 2020 Apr 16;94(9). doi: 10.1128/JVI.02170-19.
4
Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription.丝氨酸-精氨酸蛋白激酶 1 调节埃博拉病毒转录。
mBio. 2020 Feb 25;11(1):e02565-19. doi: 10.1128/mBio.02565-19.
5
Perspectives towards antiviral drug discovery against Ebola virus.针对埃博拉病毒的抗病毒药物研发的展望。
J Med Virol. 2019 Dec;91(12):2029-2048. doi: 10.1002/jmv.25357. Epub 2019 Sep 30.
6
Ebola Virus Causes Intestinal Tract Architectural Disruption and Bacterial Invasion in Non-Human Primates.埃博拉病毒导致非人类灵长类动物肠道结构破坏和细菌入侵。
Viruses. 2018 Sep 20;10(10):513. doi: 10.3390/v10100513.